Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1983-09-30
1987-02-24
Nucker, Christine M.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
436519, 436520, 436536, 436537, 436548, 436811, 436813, 436503, 935104, 935106, 935108, 935110, G01N 3353, G01N 33554, G01N 33577
Patent
active
046457380
ABSTRACT:
Two monoclonal antibodies (3-3 and 3-40) were produced which identify two new leukemia associated antigens. Both antibodies reacted with most cell lines derived from patients with T lymphoblastic leukemia (T-ALL), but were not detected on suspensions of normal hematopoietic cells, including thymocytes, by cytotoxicity, absorption of indirect immunofluorescence assays. Analysis of fresh leukemic cells indicated that mAb 3-3 only reacted with T-ALL cells, while mAb 3-40 reacted with some non-T non-B ALL cells and a few acute myelocytic leukemia (AML) cells, as well as T-ALL cells. The 3-40 antigen was also found histopathologically in frozen sections of several normal tissues, including the epithelial cells and a few lymphoid cells of the thymus, and some malignant tissues, while the 3-3 antigen was not found in any tissue studied. A "double absorption" assay provided additional serological evidence the the two antibodies identify different antigenic determinants. Biochemical analysis indicated that the molecules immunoprecipitated by mAb 3-3 and mAb 3-40 have molecular weights of 35-40,000 daltons. It is demonstrated that the 3-3 and 3-40 antigens are markers for human T-ALL and can be used along with the normal T lymphocyte antigen, 3A1, to discriminate T-ALL from cutaneous T-cell lymphoma (CTCL), adult T cell leukemia (ATL) and T cell chronic lymphocytic leukemia (T-CLL).
REFERENCES:
patent: 4361549 (1982-11-01), Kung et al.
patent: 4361550 (1982-11-01), Kung et al.
patent: 4363799 (1982-12-01), Kung et al.
patent: 4364937 (1982-12-01), Kung et al.
patent: 4381295 (1983-04-01), Kung et al.
Bai et al., Evr. J. Immunol., 131 (1983) 521-7.
Deng et al., The Lancet, 1/2/82, 10-11.
Reinherz et al., J. Immunol. 123 (1979) 1312-7.
Reinherz et al., Proc. Natl. Acad. Sci. USA, 77 (1980) 1588-92.
Knowles, II et al., Blood, 62 (1983) 191-9.
Haynes et al., Proc. Natl. Acad. Sci. USA, 76 (1989) 1529-33.
Naito et al., Blood, 62 (1983) 852-5.
Dupont Bo
Knowles Robert W.
Morishima Yasuo
Naito Kazuyuki
Memorial Sloan-Kettering Institute Cancer Center
Nucker Christine M.
LandOfFree
Method for differential diagnosis of T cell leukemias using mono does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for differential diagnosis of T cell leukemias using mono, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for differential diagnosis of T cell leukemias using mono will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-108955